What is the primary business of McKesson Corporation?

While the provided text does not explicitly detail McKesson's business operations, as a major healthcare company, it is generally known to be involved in the distribution of pharmaceuticals and medical supplies, as well as providing technology solutions for healthcare providers.

Where can I find the specific financial results for the quarter ending December 31, 2008?

The specific financial results would be detailed within the "Condensed Consolidated Financial Statements" section, specifically the "Condensed Consolidated Statements of Operations" for the quarter, and further elaborated in the "Management's Discussion and Analysis of Financial Condition and Results of Operations."

What are the key risks disclosed in this filing?

The filing lists a "Risk Factors" section, which would contain specific disclosures regarding potential risks that could affect McKesson's business, financial condition, or results of operations. Investors should review this section for a comprehensive understanding of potential challenges.

Is McKesson Corporation a financially stable company based on this report?

This report provides a snapshot of the company's financial condition as of December 31, 2008. A full assessment of financial stability requires a detailed review of the balance sheet, income statement, cash flow statement, and management's commentary on trends and outlook, none of which are fully provided in the table of contents.

MCK 10-Q Quarterly Report Q3 FY2009 — Revenue, Net Income, EPS

Summary

McKesson Corporation's (MCK) third-quarter report for the period ending December 31, 2008, indicates a company operating within its established business segments. The filing provides condensed consolidated financial statements and management's discussion and analysis, offering a look into the company's performance and financial health during this fiscal period. Investors should pay close attention to the operational results and any commentary on market conditions that may affect future performance. While the provided text is a table of contents and does not include the detailed financial figures, the structure of the 10-Q suggests that the company is reporting on its revenue, expenses, profitability, and cash flows. The inclusion of "Legal Proceedings" and "Risk Factors" sections suggests that potential liabilities and ongoing challenges are being disclosed, which are crucial considerations for assessing the company's overall risk profile.

Financial Highlights

26 data points

Beta

Revenue

$27.13B

0.0% Gross Margin

Net Income

-$20.00M

-0.0% Net Margin

EPS (Diluted)

$-0.07

Cash & Equivalents

$1.18B

Free Cash Flow

$115.00M

Financial Statements

Beta

Revenue	$27.13B
Cost of Revenue	$25.79B
Gross Profit	$1.34B
Operating Expenses	$1.40B
Operating Income	-$54.00M
Net Income	-$20.00M
EPS (Basic)	$-0.07
EPS (Diluted)	$-0.07
Shares Outstanding (Basic)	274.00M
Shares Outstanding (Diluted)	274.00M

Key Highlights

1The filing is a Quarterly Report (10-Q) for McKesson Corporation (MCK) for the period ending December 31, 2008, filed on January 26, 2009.
2The report includes Condensed Consolidated Financial Statements (Balance Sheets, Statements of Operations, Statements of Cash Flows) and Financial Notes.
3Management's Discussion and Analysis of Financial Condition and Results of Operations is a key section for understanding performance.
4The company is incorporated in Delaware and has its principal executive offices in San Francisco, California.
5As of December 31, 2008, McKesson Corporation had 273,832,171 shares of Common Stock outstanding.
6The report indicates the company is a "Large accelerated filer," suggesting significant market capitalization and public float.
7Sections such as "Legal Proceedings" and "Risk Factors" are included, highlighting potential areas of concern for investors.

MCKESSON CORP Quarterly Report for Q3 Ended Dec 31, 2008

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions